Nanosonics Ltd (NAN) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.030x

Based on the latest financial reports, Nanosonics Ltd (NAN) has a cash flow conversion efficiency ratio of 0.030x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$6.59 Million ≈ $4.66 Million USD) by net assets (AU$219.69 Million ≈ $155.45 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Nanosonics Ltd's balance sheet to measure how much of total assets are equity-financed.

Nanosonics Ltd - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how Nanosonics Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check NAN cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Nanosonics Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Nanosonics Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Cikarang Listrindo Tbk PT
JK:POWR
0.074x
Bank of Kaohsiung Ltd
TW:2836
-0.099x
YaGuang Technology Group Co Ltd
SHE:300123
-0.035x
Siteminder Ltd
AU:SDR
0.292x
Prima Marine Public Company Limited
BK:PRM
0.094x
Guangdong Xinhui Meida Nylon Co Ltd
SHE:000782
0.113x
Teyi Pharmaceutical Group Co Ltd
SHE:002728
0.029x
Viaplay Group AB (publ)
ST:VPLAY-B
0.037x

Annual Cash Flow Conversion Efficiency for Nanosonics Ltd (2007–2025)

The table below shows the annual cash flow conversion efficiency of Nanosonics Ltd from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see NAN stock market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$209.91 Million
≈ $148.52 Million
AU$43.98 Million
≈ $31.12 Million
0.210x +67.58%
2024-06-30 AU$182.20 Million
≈ $128.92 Million
AU$22.78 Million
≈ $16.12 Million
0.125x -12.12%
2023-06-30 AU$163.86 Million
≈ $115.94 Million
AU$23.31 Million
≈ $16.50 Million
0.142x +194.74%
2022-06-30 AU$138.69 Million
≈ $98.13 Million
AU$6.70 Million
≈ $4.74 Million
0.048x -10.54%
2021-06-30 AU$135.57 Million
≈ $95.92 Million
AU$7.32 Million
≈ $5.18 Million
0.054x -70.55%
2020-06-30 AU$124.23 Million
≈ $87.90 Million
AU$22.76 Million
≈ $16.11 Million
0.183x +317.98%
2019-06-30 AU$110.08 Million
≈ $77.89 Million
AU$4.83 Million
≈ $3.41 Million
0.044x -54.11%
2018-06-30 AU$94.30 Million
≈ $66.73 Million
AU$9.01 Million
≈ $6.37 Million
0.096x -49.14%
2017-06-30 AU$87.25 Million
≈ $61.74 Million
AU$16.39 Million
≈ $11.60 Million
0.188x +230.12%
2016-06-30 AU$56.66 Million
≈ $40.09 Million
AU$3.22 Million
≈ $2.28 Million
0.057x +204.99%
2015-06-30 AU$44.68 Million
≈ $31.61 Million
AU$-2.42 Million
≈ $-1.71 Million
-0.054x +57.31%
2014-06-30 AU$20.43 Million
≈ $14.46 Million
AU$-2.59 Million
≈ $-1.84 Million
-0.127x +38.85%
2013-06-30 AU$21.71 Million
≈ $15.36 Million
AU$-4.51 Million
≈ $-3.19 Million
-0.208x -7.33%
2012-06-30 AU$26.00 Million
≈ $18.40 Million
AU$-5.03 Million
≈ $-3.56 Million
-0.193x +69.26%
2011-06-30 AU$14.31 Million
≈ $10.12 Million
AU$-9.00 Million
≈ $-6.37 Million
-0.629x -91.15%
2010-06-30 AU$23.58 Million
≈ $16.69 Million
AU$-7.76 Million
≈ $-5.49 Million
-0.329x +41.23%
2009-06-30 AU$16.31 Million
≈ $11.54 Million
AU$-9.14 Million
≈ $-6.46 Million
-0.560x -92.78%
2008-06-30 AU$24.56 Million
≈ $17.38 Million
AU$-7.13 Million
≈ $-5.05 Million
-0.291x -98.38%
2007-06-30 AU$31.32 Million
≈ $22.16 Million
AU$-4.59 Million
≈ $-3.25 Million
-0.146x --

About Nanosonics Ltd

AU:NAN Australia Medical Instruments & Supplies
Market Cap
$672.36 Million
AU$950.25 Million AUD
Market Cap Rank
#10621 Global
#277 in Australia
Share Price
AU$3.18
Change (1 day)
+1.27%
52-Week Range
AU$2.98 - AU$4.73
All Time High
AU$8.25
About

Nanosonics Limited operates as an infection prevention company in Australia, North America, Europe, the United Kingdom, the Middle East, and Asia Pacific. The company manufactures and distributes trophon ultrasound probe disinfector, and its related consumables and accessories; and research, develops, and commercialize of infection control and decontamination products and related technologies. It… Read more